Intravenous stem cell and exosome therapy
Systemic infusion protocols intended to support recovery, immune function and inflammatory load. The programme where we decline the most patients, and the one where honesty matters most.
What the treatment is
Rather than being placed in a specific joint or tissue, the material is infused intravenously so that it circulates. The intention is systemic: to influence inflammatory signalling and support recovery across the body rather than in one location.
This is also the programme where claims in this industry become most extravagant. Systemic administration is often marketed as a treatment for whatever the patient happens to have. It is not, and the section below on what we decline is the most important part of this page.
How the infusion is given
Who it helps
- General recovery support alongside conventional care
- Inflammatory load in patients otherwise well
- Fatigue and recovery after illness, where investigated
- Patients pursuing wellness and longevity goals with realistic expectations
- Adjunct use alongside one of our other programmes
Where this stops working
Who it will not help
Active malignancy. Mesenchymal cells influence tissue signalling and vascularisation, and the interaction with an active tumour is not adequately characterised. We decline, and we would advise caution about any clinic that does not.
Late-stage neurodegenerative disease — Alzheimer's, Parkinson's, ALS and similar. These are advertised widely by clinics in this field. Families facing such a diagnosis are the most motivated patients in medicine, which is exactly why we will not take their money: the published evidence does not support meaningful benefit.
Patients who have stopped conventional treatment in order to pursue this instead. We will ask you to resume it, and in some cases we will decline entirely.
The protocol
Confirmed by the physician after reviewing your case, and fixed once you have been quoted. If the plan changes, the price does not change without your agreement.
Priced per protocol. Screening bloodwork required before treatment is arranged with your own physician and is not included in the published price.
- Ampoules per protocolTBC
- Cells administered per infusionTBC
- Infusion sessionsTBC
- Time per infusionTBC
- Pre-treatment screening requiredTBC
- Observation after infusionTBC
What to expect
Effects, where reported, are gradual and general rather than specific — energy, sleep and recovery are the things patients most often mention. These are subjective and difficult to measure, which is precisely why we are cautious about claiming them.
If you are looking for a treatment for a named disease, this is not it, and we would rather you heard that here than after a flight.
- Treatment or reversal of any named disease
- Benefit in neurodegenerative conditions
- A replacement for conventional medical care
- Measurable change in any specific biomarker
- Outcomes of the kind advertised elsewhere in this industry
Questions about this programme
No. Other clinics do advertise this. The published evidence does not support meaningful benefit, and the cost to families — financial and emotional — is considerable. We decline these cases.
We consider these only as an adjunct to conventional treatment, never as a replacement. Three conditions must all be met: you remain under the care of your treating specialist, that specialist knows about the plan, and you are not in an active flare. Position pending physician sign-off.
Because it requires substantially more material. The price reflects the quantity involved, not a difference in expected benefit.
Find out whether we can help you
A few questions about your condition, reviewed by a physician at no cost. If regenerative therapy isn't right for your case, we will tell you that instead of selling you something.
Start the case reviewA physician replies within two working days. No obligation, no payment at this stage.